Indopoly Swakarsa Industry Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Indopoly Swakarsa Industry Tbk trades at Rp106 (market cap 689.44B, 236.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Indopoly Swakarsa Industry Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 236.1K). Which is the better fit depends on your goals.
| IPOL | LABS | |
|---|---|---|
Market Cap | 689.44B | 576.7B |
Volume | 236.1K | 3.48M |
Lot | 2.36K | 34.82K |
Turnover | 25.04M | 522.79M |
Average Price | 106.05 | 150.13 |
Value | 25.04M | 522.79M |
Indicative Equilibrium Price | 106 | 148 |
Indicative Equilibrium Volume | 18 | 350 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on IPOL →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →